Enveric Biosciences, Inc. (ENVB)
Pharmaceutical Preparations
Latest Price
$1.57
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
3.35
P/B Ratio
0.47
Institutional Ownership
2.9% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 32.1K | -- | 1.70% | -- | 2026-03-31 |
| AdvisorShares Investments LLC | 17.0K | -- | 0.90% | -- | 2026-03-31 |
| UBS Group AG | 3.6K | -- | 0.19% | +717 | 2026-03-31 |
| Tower Research Capital LLC (TRC) | 1.1K | -- | 0.06% | -814 | 2026-03-31 |
| JONES FINANCIAL COMPANIES LLLP | 1.0K | -- | 0.05% | -- | 2026-03-31 |
| SBI Securities Co., Ltd. | 83 | -- | 0.00% | +34 | 2026-03-31 |
| BlackRock, Inc. | 51 | -- | 0.00% | -- | 2026-03-31 |
| DANSKE BANK A/S | 1 | -- | 0.00% | -- | 2026-03-31 |
| WELLS FARGO & COMPANY/MN | 1 | -- | 0.00% | -- | 2026-03-31 |
| NATIONAL BANK OF CANADA /FI/ | 1 | -- | 0.00% | -- | 2026-03-31 |